Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical trials show approximately 1015% weight reduction over 68 weeks in adults with obesity, comparable to lower-dose injectable semaglutide due to different pharmacokinetics
Step 3: Prior Authorization & Medication Delivery Upon prescription, Klinic manages the prior authorization process with your insurer, ensuring you receive the necessary approvals
Constipation and digestive discomfort Constipation on tirzepatide is the second most common gastrointestinal complaint after nausea
The key lies in respecting your body's natural balance rather than overwhelming it with mega-doses
Have more questions before you schedule a new patient visit
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
US$ 24.67
US$ 22.80
US$ 20.05
US$ 29.86
US$ 20.82
US$ 26.28
US$ 29.81
US$ 23.14
US$ 27.13
US$ 25.87
US$ 28.17
